<!DOCTYPE html>
<html lang="en" class="astro-PSTXOTMS">
	<head>
		<meta charset="utf-8">
		<meta name="viewport" content="width=device-width">
		<link rel="icon" type="image/x-icon" href="/donor-wall/favicon.ico">
    <title>Article View: GlenMelby</title>
		
    <script>
      window.CSS.registerProperty({
        name: '--top-color',
        syntax: '<color>',
        inherits: true,
        initialValue: "red"
      });
      window.CSS.registerProperty({
        name: '--bottom-color',
        syntax: '<color>',
        inherits: true,
        initialValue: "red"
      });
    </script>
	<link rel="stylesheet" href="/donor-wall/assets/baf6c709.43ef9751.css" />
<link rel="stylesheet" href="/donor-wall/assets/astro-article-_article_-astro-article-index-article-astro-name-name.ccbf68fd.css" />
<link rel="stylesheet" href="/donor-wall/assets/astro-article-_article_-astro-article-index-article.19d2464e.css" />
<link rel="stylesheet" href="/donor-wall/assets/astro-article-_article_-astro-article-index.47044b48.css" /><script type="module" src="/donor-wall/hoisted.4f82a859.js"></script></head>
	<body class="astro-PSTXOTMS">
		<main class="astro-PSTXOTMS" id="">
      <article id="story" class="story astro-JWUSBZEQ" style="--bottom-color: #4572ab; --top-color: #45A3AB">

  <div class="story__container astro-JWUSBZEQ">
		<div class="cover astro-JWUSBZEQ">
      <img id="Image" alt="" class="cover__img astro-JWUSBZEQ" src="/content/images/1H6dSTCwIsW92qe3zsf63t.jpg">
    </div>

		<div id="Content" class="row astro-JWUSBZEQ">

      <style>astro-island,astro-slot{display:contents}</style><script>(self.Astro = self.Astro || {}).load = (getHydrateCallback) => {
  (async () => {
    let hydrate = await getHydrateCallback();
    await hydrate();
  })();
};var _a;
{
  const propTypes = {
    0: (value) => value,
    1: (value) => JSON.parse(value, reviver),
    2: (value) => new RegExp(value),
    3: (value) => new Date(value),
    4: (value) => new Map(JSON.parse(value, reviver)),
    5: (value) => new Set(JSON.parse(value, reviver)),
    6: (value) => BigInt(value),
    7: (value) => new URL(value)
  };
  const reviver = (propKey, raw) => {
    if (propKey === "" || !Array.isArray(raw))
      return raw;
    const [type, value] = raw;
    return type in propTypes ? propTypes[type](value) : void 0;
  };
  if (!customElements.get("astro-island")) {
    customElements.define(
      "astro-island",
      (_a = class extends HTMLElement {
        constructor() {
          super(...arguments);
          this.hydrate = () => {
            if (!this.hydrator || this.parentElement?.closest("astro-island[ssr]")) {
              return;
            }
            const slotted = this.querySelectorAll("astro-slot");
            const slots = {};
            const templates = this.querySelectorAll("template[data-astro-template]");
            for (const template of templates) {
              if (!template.closest(this.tagName)?.isSameNode(this))
                continue;
              slots[template.getAttribute("data-astro-template") || "default"] = template.innerHTML;
              template.remove();
            }
            for (const slot of slotted) {
              if (!slot.closest(this.tagName)?.isSameNode(this))
                continue;
              slots[slot.getAttribute("name") || "default"] = slot.innerHTML;
            }
            const props = this.hasAttribute("props") ? JSON.parse(this.getAttribute("props"), reviver) : {};
            this.hydrator(this)(this.Component, props, slots, {
              client: this.getAttribute("client")
            });
            this.removeAttribute("ssr");
            window.removeEventListener("astro:hydrate", this.hydrate);
            window.dispatchEvent(new CustomEvent("astro:hydrate"));
          };
        }
        connectedCallback() {
          if (!this.hasAttribute("await-children") || this.firstChild) {
            this.childrenConnectedCallback();
          } else {
            new MutationObserver((_, mo) => {
              mo.disconnect();
              this.childrenConnectedCallback();
            }).observe(this, { childList: true });
          }
        }
        async childrenConnectedCallback() {
          window.addEventListener("astro:hydrate", this.hydrate);
          await import(this.getAttribute("before-hydration-url"));
          const opts = JSON.parse(this.getAttribute("opts"));
          Astro[this.getAttribute("client")](
            async () => {
              const rendererUrl = this.getAttribute("renderer-url");
              const [componentModule, { default: hydrator }] = await Promise.all([
                import(this.getAttribute("component-url")),
                rendererUrl ? import(rendererUrl) : () => () => {
                }
              ]);
              this.Component = componentModule[this.getAttribute("component-export") || "default"];
              this.hydrator = hydrator;
              return this.hydrate;
            },
            opts,
            this
          );
        }
        attributeChangedCallback() {
          if (this.hydrator)
            this.hydrate();
        }
      }, _a.observedAttributes = ["props"], _a)
    );
  }
}</script><astro-island uid="Z2m3SBv" component-url="/donor-wall/StoryMeta.c7027780.js" component-export="default" renderer-url="/donor-wall/client.b27523fa.js" props="{&quot;class&quot;:[0,&quot;meta astro-JWUSBZEQ&quot;],&quot;firstName&quot;:[0,&quot;Glen&quot;],&quot;lastName&quot;:[0,&quot;Melby&quot;],&quot;year&quot;:[0,null],&quot;organ&quot;:[0,null],&quot;date&quot;:[0,null],&quot;topColor&quot;:[0,&quot;var(--top-color)&quot;],&quot;bottomColor&quot;:[0,&quot;var(--bottom-color)&quot;]}" ssr="" client="load" before-hydration-url="data:text/javascript;charset=utf-8,//[no before-hydration script]" opts="{&quot;name&quot;:&quot;StoryMeta&quot;,&quot;value&quot;:true}" await-children=""><section class="meta meta astro-JWUSBZEQ svelte-128zb44"><div id="Circle" class="circle svelte-128zb44"><svg class="graphic circle__img svelte-1aoszpq" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 100 100"><defs><clipPath id="clippath"><circle cx="50" cy="50" r="45" fill="none"></circle></clipPath><filter id="glass_filter"><feTurbulence type="fractalNoise" baseFrequency="0.04 0.04" numOctaves="14" seed="23" stitchTiles="stitch" x="0%" y="0%" width="100%" height="100%" result="turbulence"></feTurbulence><feMorphology operator="dilate" radius="3 3" x="0%" y="0%" width="100%" height="100%" in="turbulence" result="morphology"></feMorphology><feDisplacementMap in="SourceGraphic" in2="morphology" scale="25" xChannelSelector="R" yChannelSelector="B" x="9%" y="10%" width="100%" height="100%" result="displacementMap"></feDisplacementMap><feSpecularLighting surfaceScale="4" specularConstant="1.4" specularExponent="72" x="0%" y="0%" id="lighting-color" in="turbulence" lighting-color="var(--top-color)" width="100%" height="100%" result="specularLighting1"><fePointLight x="50" y="0" z="800"></fePointLight></feSpecularLighting><feGaussianBlur stdDeviation=".5" x="0%" y="0%" width="300%" height="300%" in="specularLighting1" edgeMode="duplicate" result="blur1"></feGaussianBlur><feFlood id="base-color" flood-color="var(--bottom-color)" flood-opacity="1" x="0%" y="0%" width="100%" height="100%" result="flood"></feFlood><feBlend mode="screen" x="0%" y="0%" width="100%" height="100%" in="specularLighting" in2="flood" result="blend"></feBlend><feBlend mode="soft-light" x="0%" y="0%" width="100%" height="100%" in="SourceGraphic" in2="blend" result="blend1"></feBlend></filter></defs><circle class="circle-stroke svelte-1aoszpq" cx="50" cy="50" r="45.75" stroke="white" stroke-width="3"></circle><g clip-path="url(#clippath)" class="glass"><image clip-path="url(#clippath)" x="-100" y="-355" class="glass__bg svelte-1aoszpq" width="300" height="800" style="opacity: .9" xlink:href="/donor-wall/assets/streaks-small.efa45366.jpg" filter="url(#glass_filter)"></image><image clip-path="url(#clippath)" x="-50" y="-50" class="glass__front svelte-1aoszpq" width="300" height="300" xlink:href="/donor-wall/assets/glass-front-bw.adf7dd2b.webp"></image></g><svg class="text  svelte-1aoszpq" viewBox="0 0 100 100" width="80" height="80" x="10" y="11"><g class="text__wrapper svelte-1aoszpq" fill="var(--top-color)" width="100"><text x="50" y="32" text-anchor="middle" class="text__first-name svelte-1aoszpq">Glen</text><text text-anchor="middle" class="text__last-name svelte-1aoszpq" x="50" y="59" textLength="50" lengthAdjust="spacing">Melby</text><text dx="50" y="78" textLength="35" text-anchor="middle" class="text__year">2022</text></g></svg></svg></div>

  <div class="meta__container svelte-128zb44"><div id="Name" class="meta__title svelte-128zb44"><astro-slot>Glen benefitted twice from clinical trials for his lung cancer</astro-slot></div>

    <div id="Organ" class="meta__organ svelte-128zb44"></div>

    <div id="Date" class="meta__date"></div></div>
</section></astro-island>

			<section id="Story" class="story__content astro-JWUSBZEQ">
        <p>Glen Melby is happy to discuss potential benefits of clinical trials with just about anyone, because he has experienced those benefits. Twice.</p><p>Melby was first diagnosed with non-small cell <span>type: entry-hyperlink id: 13226</span> (NSCLC) in 2008. He began radiation and chemotherapy, and while treatments eliminated most evidence of the disease, he said side effects were nearly unbearable. A year later, the cancer was back.</p><p>It was then Dr. Walter Vogel, his oncologist at the Beloit Cancer Center, mentioned a possible new treatment option. Based on the results of an NSCLC clinical trial, the Food and Drug Administration (FDA) had just months prior fast-tracked the approval of a targeted drug therapy, Crizotinib, for patients whose tumors had a mutation in the ALK gene. Melby’s tumor was sequenced and found to be one of the roughly 4 percent of NSCLCs that are ALK+. He began taking Crizotonib almost immediately.</p><p>“You just don’t see oncologists be giddy, but after Glen’s first PET scan after he started the drug, Dr. Vogel was,” said Dianne Melby, Glen’s wife.</p><p>For nearly two years, Melby took Crizotonib, an oral drug that targets ALK-mutated cancer cells and therefore has fewer side effects than standard chemotherapy.</p><p>However, his cancer grew resistant to Crizotonib, and Vogel referred Melby to Dr. <span>type: entry-hyperlink id: P7750</span> at the <span>type: entry-hyperlink id: 15041</span>. Traynor offered him an option to enroll in a clinical trial to investigate a next-generation ALK-targeted therapy, Alectinib.</p><p>“After having such success with Crizotinib, stepping into this trial was a no-brainer for me,” Melby said.</p><p>He began the trial in February 2014. While his cancer is still detectable by scans, there has been no further advancement of the disease.</p><p>“This drug has been wonderful for me,” Melby said. “The fact that side effects are minimal, the fact that I go on with my life, I go to Florida to see my grandkids. It’s been over seven years since I was diagnosed with an aggressive cancer, and I’m still here.”</p><p>Traynor noted future patients would benefit from Melby’s participation in the Alectinib trial, just as he had benefitted from those who had enrolled in the Crozotinib trial.</p><p>“Without brave patients like Glen enrolling in trials, cancer science cannot move forward,” Traynor said.</p>
      </section>

		</div>
	</div>

  <div class="shadow svelte-hxrkwh" style="--color-1: var(--bottom-color); --color-2: var(--top-color);"></div>
<footer class="astro-JWUSBZEQ svelte-hxrkwh" style="--color-1: var(--bottom-color); --color-2: var(--top-color);"><div class="content content--left svelte-hxrkwh">Use your phone&#39;s camera To scan the qr code</div>
  <div class="qrcode svelte-hxrkwh"><div class="qrcode__container svelte-hxrkwh"><img class="qrcode__img svelte-hxrkwh" alt="" src="/donor-wall/assets/uwhorg-qr.ba8c0c85.png"></div></div>
  <div class="content content--right svelte-hxrkwh">View legacy donors, read stories, donate, and more</div>
</footer>

</article>




    </main>
  </body></html>